Boston Scientific to acquire Bayer unit for $415M

|About: Bayer A.G. ADR (BAYRY)|By:, SA News Editor

Boston Scientific (BSX) has agreed to acquire Bayer's (BAYRY) Interventional device business for $415M.

The deal that will strengthen Boston's portfolio of products for treating peripheral vascular disease, with the company to receive systems used in cardiology, radiology and peripheral vascular procedures.

The unit generated $120M in sales last year. (PR)